Canonical and Truncated Transglutaminase-2 Regulate Mucin-1 Expression and Androgen Independency in Prostate Cancer Cell Lines

The authors reported that silencing of transglutaminase-2 expression by CRISPR-Cas9 was associated with upregulation of androgen receptor transcription in prostate cancer cell lines.